HC006
/ HC Biopharma
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
March 18, 2026
A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=331 | Recruiting | Sponsor: HC Biopharma Inc.
New P1 trial • Oncology • Solid Tumor
July 17, 2025
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=252 | Recruiting | Sponsor: HC Biopharma Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Solid Tumor
May 09, 2025
Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=252 | Not yet recruiting | Sponsor: HC Biopharma Inc.
New P1 trial • Oncology • Solid Tumor
March 12, 2024
A Study of HC006 in Subjects With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=76 | Recruiting | Sponsor: HC Biopharma Inc.
Metastases • New P1 trial • Oncology • Solid Tumor
1 to 4
Of
4
Go to page
1